IN2015MU00907A - - Google Patents

Info

Publication number
IN2015MU00907A
IN2015MU00907A IN907MU2015A IN2015MU00907A IN 2015MU00907 A IN2015MU00907 A IN 2015MU00907A IN 907MU2015 A IN907MU2015 A IN 907MU2015A IN 2015MU00907 A IN2015MU00907 A IN 2015MU00907A
Authority
IN
India
Prior art keywords
sustained release
compositions
semisynthetic
carriers
preparing
Prior art date
Application number
Other languages
English (en)
Inventor
Harshal Ashok Pawar
K G Lalitha
Original Assignee
Harshal Ashok Pawar
K G Lalitha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harshal Ashok Pawar, K G Lalitha filed Critical Harshal Ashok Pawar
Priority to IN907MU2015 priority Critical patent/IN2015MU00907A/en
Publication of IN2015MU00907A publication Critical patent/IN2015MU00907A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN907MU2015 2015-03-19 2015-03-19 IN2015MU00907A (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN907MU2015 IN2015MU00907A (tr) 2015-03-19 2015-03-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN907MU2015 IN2015MU00907A (tr) 2015-03-19 2015-03-19

Publications (1)

Publication Number Publication Date
IN2015MU00907A true IN2015MU00907A (tr) 2015-04-24

Family

ID=54394482

Family Applications (1)

Application Number Title Priority Date Filing Date
IN907MU2015 IN2015MU00907A (tr) 2015-03-19 2015-03-19

Country Status (1)

Country Link
IN (1) IN2015MU00907A (tr)

Similar Documents

Publication Publication Date Title
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
NZ742220A (en) Pharmaceutical compositions comprising meloxicam
MX2021000550A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.
MY187047A (en) Selective pyy compounds and uses thereof
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015500823A1 (en) Modified release formulations for oprozomib
EP4360621A3 (en) Formulations of bendamustine
PH12017502376A1 (en) Oral solid formulation containing irinotecan and method of preparing the same
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12016501841A1 (en) Immunosuppressant formulation
MX2017009289A (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
EA201691741A1 (ru) Фармацевтическая композиция
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
MX2015015537A (es) Formulacion de pastillas de nicotina.
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
IN2015MU00907A (tr)
PH12016502527A1 (en) Stabilized desmopressin
PH12018500946A1 (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
TR201721065A2 (tr) Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar
IN2014MU01179A (tr)
MX2015013279A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.